Lantern Pharma LTRN
Lantern Pharma: annual report (amended)
- Form
- 10-K/A
- Filed
- Importance
- Routine
- Accession
- 0001493152-26-019713
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Kezar Life Sciences KZR public float $33M, Jun 30, 2025
- Grace Therapeutics GRCE public float $35M, Sep 30, 2025
- Insight Molecular Diagnostics IMDX public float $32M, Jun 30, 2025
- Rein Therapeutics RNTX public float $32M, Jun 30, 2025
- Yarrow Bioscience VYNE public float $32M, Jun 30, 2025